Global Transdermal Patch Market 2022 - Snapshot
The global transdermal patch market is anticipated to increase by USD 3 billion till 2028 at an average annual growth of 4.8 percent as per the latest report by Gen Consulting Company.
This industry report offers market estimates of the global market, followed by a detailed analysis of the type, application, and region. The global market data on transdermal patch can be segmented by type: single-layer drug-in-adhesive, multi-layer drug-in-adhesive, matrix, others. The matrix segment is estimated to account for the largest share of the global transdermal patch market. Transdermal patch market is further segmented by application: pain management, smoking cessation aid, overactive bladder (OAB), hormonal therapy, others. The pain management segment held the largest revenue share in 2021. Based on region, the transdermal patch market is segmented into: North America, Europe, Asia-Pacific, MEA (Middle East and Africa), Latin America. Globally, North America made up the largest share of the transdermal patch market.
The global transdermal patch market is highly competitive. Top players covered in Global Transdermal Patch Market Study are 3M Company, Henan Lingrui Pharmaceutical Ltd, Luye Pharma Group Ltd., Novartis AG, Purdue Pharma Manufacturing LP, Samyang Biopharmaceuticals Corp. (Samyang Holdings Corporation), Teikoku Seiyaku Co. Ltd., Teva Pharmaceutical Industries Ltd., Viatris Inc.
The data-centric report focuses on market trends, status and outlook for segments. With comprehensive market assessment across the major geographies, the report is a valuable asset for the existing players, new entrants and the future investors.
Why buy this report?
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.Download eBook